MoneyWorks4Me

Lupin informs about press release

07 Jan 2022 Evaluate

Lupin has informed that it enclosed is a Press Release as regards launch of Molnupiravir by the Company under the brand name Molnulup for the treatment of COVID-19 in adults in India. This may be considered as a disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1759.75
Dr. Reddys Labs. 1321.00
Cipla 1364.90
Lupin 1958.30
Zydus Lifesciences 1171.35
View more..